Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Russell Hoverman

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Cancer Medicine|June 12, 2020
Rethinking clinical oncology drug research in an era of value-based cancer care: A role for chemotherapy pathwaysJ Russell Hoverman
The American Journal of Managed Care|May 31, 2012
Value-based reimbursement in oncologyMichael Kolodziej, J Russell Hoverman
Disease Management : DM|July 2, 2004
Lung cancer: a cost and outcome study based on physician practice patternsJ Russell Hoverman, S Marciann Robertson
JCO Oncology Practice|July 15, 2021
Affirming the Value of Clinical Chemotherapy Pathways ProgramsJ Russell Hoverman, Aimee Ginsburg, Lalan Wilfong, et al.
Cancer Journal (Sudbury, Mass.)|May 25, 2017
The Affordable Care Act and Cancer Care DeliveryGabriel A Brooks, J Russell Hoverman, Carrie H Colla
Journal of Oncology Practice|March 19, 2015
Improving incidence of code status documentation through process and disciplineMarcus A Neubauer, Cynthia B Taniguchi, J Russell Hoverman
The American Journal of Managed Care|June 23, 2025
Utilization and costs among oncologists participating in a private insurance shared savings modelBrigham Walker, Lalan Wilfong, Nicholas Robert, et al.
Journal of Oncology Practice|September 4, 2012
Impact of payment reform on chemotherapy at the end of lifeCarrie H Colla, Nancy E Morden, Jonathan S Skinner, et al.
The American Journal of Managed Care|June 15, 2012
Impact of payment reform on chemotherapy at the end of lifeCarrie H Colla, Nancy E Morden, Jonathan S Skinner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2013
Defining cancer care quality or delivering quality cancer care?Matt Brow, J Russell Hoverman, Debra Patt, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Cancer Medicine|June 12, 2020
Rethinking clinical oncology drug research in an era of value-based cancer care: A role for chemotherapy pathwaysJ Russell Hoverman
The American Journal of Managed Care|May 31, 2012
Value-based reimbursement in oncologyMichael Kolodziej, J Russell Hoverman
Disease Management : DM|July 2, 2004
Lung cancer: a cost and outcome study based on physician practice patternsJ Russell Hoverman, S Marciann Robertson
JCO Oncology Practice|July 15, 2021
Affirming the Value of Clinical Chemotherapy Pathways ProgramsJ Russell Hoverman, Aimee Ginsburg, Lalan Wilfong, et al.
Cancer Journal (Sudbury, Mass.)|May 25, 2017
The Affordable Care Act and Cancer Care DeliveryGabriel A Brooks, J Russell Hoverman, Carrie H Colla
Journal of Oncology Practice|March 19, 2015
Improving incidence of code status documentation through process and disciplineMarcus A Neubauer, Cynthia B Taniguchi, J Russell Hoverman
The American Journal of Managed Care|June 23, 2025
Utilization and costs among oncologists participating in a private insurance shared savings modelBrigham Walker, Lalan Wilfong, Nicholas Robert, et al.
Journal of Oncology Practice|September 4, 2012
Impact of payment reform on chemotherapy at the end of lifeCarrie H Colla, Nancy E Morden, Jonathan S Skinner, et al.
The American Journal of Managed Care|June 15, 2012
Impact of payment reform on chemotherapy at the end of lifeCarrie H Colla, Nancy E Morden, Jonathan S Skinner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2013
Defining cancer care quality or delivering quality cancer care?Matt Brow, J Russell Hoverman, Debra Patt, et al.
Pageof 4